NASDAQ:DOMH

Dominari (DOMH) Stock Price, News & Analysis

$2.14
+0.05 (+2.39%)
(As of 05/17/2024 ET)
Today's Range
$2.02
$2.26
50-Day Range
$2.05
$3.14
52-Week Range
$1.76
$3.40
Volume
4,610 shs
Average Volume
11,338 shs
Market Capitalization
$12.69 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
DOMH stock logo

About Dominari Stock (NASDAQ:DOMH)

Dominari Holdings Inc., a biotechnology company, focuses on developing small-molecule anticancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as AIkido Pharma Inc. and changed its name to Dominari Holdings Inc. in December 2022. Dominari Holdings Inc. was founded in 1967 and is headquartered in New York, New York.

DOMH Stock Price History

DOMH Stock News Headlines

Thursday 4/6 Insider Buying Report: PL, DOMH
Kyle Wool Named CEO of Dominari Financial
See More Headlines
Receive DOMH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Dominari and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/09/2024
Today
5/17/2024
Next Earnings (Estimated)
8/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Security brokers & dealers
Sub-Industry
N/A
Current Symbol
NASDAQ:DOMH
Web
N/A
Employees
26
Year Founded
N/A

Profitability

Net Income
$-22,880,000.00
Net Margins
-721.11%
Pretax Margin
-721.11%

Debt

Sales & Book Value

Annual Sales
$2.04 million
Book Value
$8.03 per share

Miscellaneous

Free Float
5,357,000
Market Cap
$12.39 million
Optionable
Not Optionable
Beta
0.92
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Mr. Anthony C. Hayes Esq. (Age 56)
    CEO & Chairman
    Comp: $1M
  • Mr. Kyle Michael Wool (Age 46)
    President & Director
    Comp: $600.36k
  • Mr. George Michael Way CPA (Age 56)
    Chief Financial Officer
  • Mr. Christopher Devall (Age 41)
    Chief Operating Officer
    Comp: $350k
  • Mr. Matthew B. McCullough (Age 38)
    General Counsel
  • Mr. Jaime Mercado Jr.
    Chief Compliance Officer

DOMH Stock Analysis - Frequently Asked Questions

How have DOMH shares performed in 2024?

Dominari's stock was trading at $2.59 on January 1st, 2024. Since then, DOMH stock has decreased by 17.4% and is now trading at $2.14.
View the best growth stocks for 2024 here
.

When is Dominari's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 14th 2024.
View our DOMH earnings forecast
.

How were Dominari's earnings last quarter?

Dominari Holdings Inc. (NASDAQ:DOMH) issued its quarterly earnings results on Thursday, May, 9th. The company reported ($0.35) earnings per share for the quarter. The firm earned $1.37 million during the quarter. Dominari had a negative net margin of 721.11% and a negative trailing twelve-month return on equity of 38.40%.

How do I buy shares of Dominari?

Shares of DOMH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:DOMH) was last updated on 5/17/2024 by MarketBeat.com Staff

From Our Partners